Circulating Tumor Cell Market Size, Share, and Growth Analysis, By Technology, By Application, By Product, By Specimen, By End Use, By Region - Industry Forecast 2025-2032
세계의 순환종양세포 시장 규모는 2023년에 122억 달러로 평가되며, 2024년 135억 5,000만 달러에서 2032년에는 314억 6,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 11.1%로 성장할 전망입니다.
세계 순환종양세포(CTC) 시장은 암 진단의 기술 혁신과 암 발병률 증가로 인해 역동적으로 성장하고 있습니다. 비침습적 진단 툴, 특히 CTC 분석에 대한 수요는 맞춤형 의료로의 전환과 암의 조기 발견에 대한 절박한 필요성에 의해 촉진되고 있습니다. 그러나 기술적 복잡성과 표준화 부족으로 인해 비침습적 진단 툴의 광범위한 보급을 가로막고 있습니다. 현재 ELISA법과 PCR법이 제품의 주류를 차지하고 있습니다. 북미가 큰 시장 점유율을 차지하고 있는 것은 탄탄한 의료 인프라에 기인합니다. 이 시장은 진화하는 의료 환경에 대응하고 환자 결과를 개선하기 위한 지속적인 연구 구상, 공동 연구 및 혁신적인 제품 개발로 특징지어집니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장의 전제조건과 제한
개요
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 산업 분석
주요 시장 인사이트
- 주요 성공 요인
- 경쟁의 정도
- 주요 투자 기회
- 시장 에코시스템
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
순환종양세포 시장 규모 : 기술별 & CAGR(2025-2032)
- 시장 개요
- CTC 탐지 및 농축 방법
- 면역 포착(라벨 기반)
- 포지티브 셀렉션
- 네거티브 셀렉션
- 사이즈 기반 분리(라벨 프리)
- 막 기반
- 마이크로플루이딕스 기반
- 밀도 기반 분리(라벨 프리)
- 조합 방법
- CTC 직접 검출법
- CTC 분석
순환종양세포 시장 규모 : 용도별 & CAGR(2025-2032)
- 시장 개요
- 임상/액체생검
- 조사
- 암 줄기세포와 종양 형성 조사
- 의약품·치료법 개발
순환종양세포 시장 규모 : 제품별 & CAGR(2025-2032)
- 시장 개요
- 키트와 시약
- 채혈관
- 디바이스 또는 시스템
순환종양세포 시장 규모 : 검체별 & CAGR(2025-2032)
순환종양세포 시장 규모 : 최종 용도별 & CAGR(2025-2032)
- 시장 개요
- 조사·학술기관
- 병원과 진료소
- 진단 센터
순환종양세포 시장 규모 : 지역별 & CAGR(2025-2032)
- 북미
- 유럽
- 독일
- 스페인
- 프랑스
- 영국
- 이탈리아
- 기타 유럽 지역
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- 남아프리카공화국
경쟁 정보
- 상위 5사의 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업의 기업 개요
- 기업의 상세
- 제품 포트폴리오 분석
- 기업의 부문별 점유율 분석
- 매출의 전년대비 비교(2022-2024)
주요 기업 개요
- Sysmex Corporation(Japan)
- Bio-Techne Corporation(USA)
- Thermo Fisher Scientific Inc.(USA)
- Miltenyi Biotec GmbH(Germany)
- Biolidics Limited(Singapore)
- ScreenCell(France)
- Greiner Bio-One International GmbH(Austria)
- AVIVA Biosciences(USA)
- BIOCEPT, Inc.(USA)
- Ikonisys, Inc.(USA)
- Epic Sciences(USA)
- Rarecells Diagnostics(France)
- STEMCELL Technologies, Inc.(Canada)
- Precision for Medicine(USA)
- ANGLE plc(UK)
- Creatv MicroTech, Inc.(USA)
결론과 제안
KSA
Global Circulating Tumor Cell Market size was valued at USD 12.2 billion in 2023 and is poised to grow from USD 13.55 billion in 2024 to USD 31.46 billion by 2032, growing at a CAGR of 11.1% during the forecast period (2025-2032).
The global Circulating Tumor Cell (CTC) market is witnessing dynamic growth, driven by innovations in cancer diagnostics and an increasing incidence of cancer. The demand for non-invasive diagnostic tools, particularly CTC analysis, is fueled by a shift towards personalized medicine and a pressing need for early cancer detection. However, challenges such as technological complexities and the lack of standardization hinder broader adoption. Currently, ELISA and PCR-based methods dominate the product landscape. North America commands a significant market share attributed to its robust healthcare infrastructure. The market is characterized by continuous research initiatives, collaborative efforts, and innovative product developments aimed at addressing the evolving medical landscape and enhancing patient outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Circulating Tumor Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Circulating Tumor Cell Market Segments Analysis
Global Circulating Tumor Cell Market is segmented by Technology, Application, Product, Specimen, End Use and region. Based on Technology, the market is segmented into CTC detection & enrichment methods, CTC Direct Detection Methods and CTC Analysis. Based on Application, the market is segmented into Clinical/ Liquid Biopsy and Research. Based on Product, the market is segmented into Kits & Reagents, Blood Collection Tubes and Devices or Systems. Based on specimen, the market is segmented into Blood, Bone Marrow and Other Body Fluids. Based on End Use, the market is segmented into Research and academic institutes, Hospital and clinics and Diagnostic centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Circulating Tumor Cell Market
The rising incidence of cancer worldwide has intensified the demand for advanced diagnostic tools, with circulating tumor cell (CTC) analysis gaining prominence as a non-invasive and valuable technique for cancer detection and monitoring. Additionally, the focus on personalized medicine and the urgency for early cancer diagnosis are driving the adoption of CTC technologies. This growing need for effective diagnostic solutions is reshaping the global landscape of cancer management and treatment, fostering innovation and advancements in the CTC market, which aims to provide better outcomes for patients through improved detection and monitoring capabilities.
Restraints in the Global Circulating Tumor Cell Market
One of the primary challenges facing the global circulating tumor cell (CTC) market is the technological complexity involved in CTC analysis. This intricacy complicates the process and highlights the need for standardization across various methodologies, which hinders widespread acceptance and implementation. Furthermore, concerns regarding the reliability and reproducibility of CTC results create additional barriers, making it difficult for these techniques to be integrated into standard clinical practices. As such, these factors collectively contribute to limiting the overall growth and adoption of CTC technologies in the healthcare sector, restraining market potential.
Market Trends of the Global Circulating Tumor Cell Market
The global circulating tumor cell (CTC) market is witnessing a significant trend characterized by the increasing integration of CTC analysis into routine clinical practice. This shift is driven by the technology's ability to facilitate real-time cancer progression tracking and treatment response evaluation. Advances in innovative technologies such as microfluidic systems and sophisticated molecular detection techniques are enhancing the precision and sensitivity of CTC analysis. Additionally, the rising awareness and adoption of liquid biopsy methods for cancer diagnostics underscore the critical role of CTCs as valuable biomarkers. This convergence of technology and clinical application is poised to revolutionize cancer care and diagnosis.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global Circulating Tumor Cell Market Size by Technology & CAGR (2025-2032)
- Market Overview
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- CTC Direct Detection Methods
- CTC Analysis
Global Circulating Tumor Cell Market Size by Application & CAGR (2025-2032)
- Market Overview
- Clinical/ Liquid Biopsy
- Risk Assessment
- Screening and Monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
Global Circulating Tumor Cell Market Size by Product & CAGR (2025-2032)
- Market Overview
- Kits & Reagents
- Blood Collection Tubes
- Devices or Systems
- Global Circulating Tumor Cell Market Size by Specimen & CAGR (2025-2032)
- Market Overview
- Blood
- Bone Marrow
- Other Body Fluids
Global Circulating Tumor Cell Market Size by End Use & CAGR (2025-2032)
- Market Overview
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
Global Circulating Tumor Cell Market Size & CAGR (2025-2032)
- North America (Technology, Application, Product, Specimen, End Use)
- Europe (Technology, Application, Product, Specimen, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Technology, Application, Product, Specimen, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Technology, Application, Product, Specimen, End Use)
- Brazil
- Rest of Latin America
- Middle East & Africa (Technology, Application, Product, Specimen, End Use)
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Miltenyi Biotec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biolidics Limited (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ScreenCell (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Greiner Bio-One International GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AVIVA Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BIOCEPT, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ikonisys, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Epic Sciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rarecells Diagnostics (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- STEMCELL Technologies, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Precision for Medicine (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ANGLE plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creatv MicroTech, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
